These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 3651625)
41. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. Franklyn JA; Daykin J; Holder R; Sheppard MC QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667 [TBL] [Abstract][Full Text] [Related]
42. Standard dose 131I therapy for hyperthyroidism caused by autonomously functioning thyroid nodules. Ng Tang Fui SC; Maisey MN Clin Endocrinol (Oxf); 1979 Jan; 10(1):69-77. PubMed ID: 436306 [TBL] [Abstract][Full Text] [Related]
43. [The use for recombinant human TSH in patients with toxic and non-toxic nodular goiter]. Jedrzejuk D; Milewicz A Postepy Hig Med Dosw (Online); 2005 May; 59():188-92. PubMed ID: 15928602 [TBL] [Abstract][Full Text] [Related]
44. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. Fast S; Hegedüs L; Grupe P; Nielsen VE; Bluhme C; Bastholt L; Bonnema SJ J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346 [TBL] [Abstract][Full Text] [Related]
45. [The efficacy of the radioiodine treatment of toxic thyroid adenoma and multinodular goiter]. Gómez-Arnaiz N; Maravall J; Gómez JM; Gumà A; Andía E; Mora J Rev Clin Esp; 1999 Oct; 199(10):637-40. PubMed ID: 10589246 [TBL] [Abstract][Full Text] [Related]
46. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India. Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128 [TBL] [Abstract][Full Text] [Related]
47. Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: is more than seven-thousand rad target dose necessary? Bajnok L; Mezosi E; Nagy E; Szabo J; Sztojka I; Varga J; Galuska L; Leovey A Thyroid; 1999 Sep; 9(9):865-9. PubMed ID: 10524564 [TBL] [Abstract][Full Text] [Related]
48. Acute changes in thyroid volume and function following 131I therapy of multinodular goitre. Nygaard B; Faber J; Hegedüs L Clin Endocrinol (Oxf); 1994 Dec; 41(6):715-8. PubMed ID: 7889605 [TBL] [Abstract][Full Text] [Related]
49. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake. Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144 [TBL] [Abstract][Full Text] [Related]
50. [Therapeutic results of radioiodine therapy of hyperthyroid thyroid gland diseases]. Debrand-Passard A; Barzen G; Richter W; Wenzel KW; Felix R Med Klin (Munich); 1994 Jun; 89(6):319-23. PubMed ID: 8072455 [TBL] [Abstract][Full Text] [Related]
52. Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity. Roque C; Santos FS; Pilli T; Dalmazio G; Castagna MG; Pacini F J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32320467 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the long-term efficacy of low dose 131I versus antithyroid drugs in the treatment of hyperthyroidism. Chen DY; Jing J; Schneider PF; Chen TH Nucl Med Commun; 2009 Feb; 30(2):160-8. PubMed ID: 19194213 [TBL] [Abstract][Full Text] [Related]
54. Comparison of the outcome between the calculated dosimetry and the estimated dosimetry of 131I in the treatment of hyperthyroidism. Sun JH; Huang HS; Huang MJ; Huang BY; Lin JD; Hsu BR; Chiou SC; Lo SK Changgeng Yi Xue Za Zhi; 1995 Dec; 18(4):322-8. PubMed ID: 8851980 [TBL] [Abstract][Full Text] [Related]
55. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. Andrade VA; Gross JL; Maia AL J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768 [TBL] [Abstract][Full Text] [Related]
56. [Status of 3 years of hyperthyroidism treatment with iodine 131]. Delgrange E; Weber E; Michel L; De Coster P; Buysschaert M; Donckier J Acta Clin Belg; 1994; 49(5):200-7. PubMed ID: 7992563 [TBL] [Abstract][Full Text] [Related]
57. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency. Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614 [TBL] [Abstract][Full Text] [Related]
59. Results of 131I theory for 2,000 thyrotoxic patients: do the effects depend on the dose? Zgliczynski S; Gietka-Czernel M; Gorowski T; Bednarski A; Chomicki O; Jastrzebska W; Makowska A; Niegowska E; Pucilowska J; Soszynski P Exp Clin Endocrinol; 1991 May; 97(2-3):286-91. PubMed ID: 1915646 [No Abstract] [Full Text] [Related]
60. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism. Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]